NasdaqGS:DAWNBiotechs
A Look At Day One Biopharmaceuticals (DAWN) Valuation As Earnings Expectations Build For February 2026
Day One Biopharmaceuticals (DAWN) is back in focus after the company set February 24, 2026 as the date for its Q4 2025 earnings release and accompanying conference call.
See our latest analysis for Day One Biopharmaceuticals.
At a share price of $11.70, Day One Biopharmaceuticals has a 90 day share price return of 24.07% and a year to date share price return of 32.20%. The 1 year total shareholder return is 3.94% lower, which indicates that more recent momentum has picked up ahead of the...